Charing Cross Hospital

Charing Cross Hospital is part of Imperial College Healthcare NHS Trust

Imperial College Trust is one of the largest NHS trusts in the country, covering five hospitals across central and west London with more than 14.500 staff.

The Gestational Trophoblastic Disease (GTD) service at Charing Cross Hospital is a highly specialist service providing comprehensive registration, screening and clinical management for all forms of the disease.

The internationally renowned GTD team led by Professor Michael Seckl are world leaders in the investigation and treatment of these rare conditions. Charing Cross Hospital is one of only two hospitals in the UK which treat GTD.

Research funded by CTRT is carried out at Charing Cross Hospital

Research studies funded by CTRT currently being run at Charing Cross include trials for Gestational Trophoblastic Disease. Please click below to find more details on our current research

How You Can Help

We need your support to continue running life-changing clinical trials. From hosting a coffee morning or recycling old gadgets to leaving a gift in your will, there are many ways you can help us find kinder, more effective treatments for patients with cancer.

Stay in Touch

Sign up here to receive the latest news and updates from CTRT via email